InvestorsHub Logo
Followers 3
Posts 848
Boards Moderated 0
Alias Born 11/28/2005

Re: None

Saturday, 09/05/2020 7:29:07 PM

Saturday, September 05, 2020 7:29:07 PM

Post# of 20689
Maybe the insider sales and supposed manipulation that accompanied the pps drop following the rise into the 40s after the positive nipocalimab data was because the J&J (or any) acquisition was in question and a near-term cash raise was possible instead.

https://www.fiercebiotech.com/biotech/j-j-free-from-rival-bidders-made-momenta-wait-6-5b-deal